Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-10

Clinical Trial Update: Nitazoxanide in Prevention of Secondary Spontaneous Peritonitis [Phase 3]

View source ↗

Summary

Phase 3 trial update on nitazoxanide for prevention of secondary spontaneous bacterial peritonitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Tanta University | Conditions: Spontaneous Bacterial Peritonitis | Phase 3 | Status: UNKNOWN